Similarly, CD99 represents a crucial target for identifying and isolating circulating tumor cells (CTCs), thereby aiding in the detection of potential micro metastases during the follow-up of EWS patients in the late stages of tumor progression [130]. This evidence concerns the gene CD99 and neoplasm.